Highest Analyst Upside Stocks
AORT is part of our highest analyst upside stock list, indicating analysts have a price target way above the current price.
ARTIVION INC (AORT) Stock Price & Overview
NYSE:AORT • US2289031005
Current stock price
37.76 USD
+0.6 (+1.61%)
At close:
37.76 USD
0 (0%)
After Hours:
The current stock price of AORT is 37.76 USD. Today AORT is up by 1.61%. In the past month the price increased by 3.76%. In the past year, price increased by 58.39%.
AORT Key Statistics
52-Week Range23.04 - 48.25
Current AORT stock price positioned within its 52-week range.
1-Month Range32.815 - 39.66
Current AORT stock price positioned within its 1-month range.
- Market Cap
- 1.831B
- P/E
- 209.78
- Fwd P/E
- 86.03
- EPS (TTM)
- 0.18
- Dividend Yield
- N/A
AORT Stock Performance
Today
+1.61%
1 Week
+0.11%
1 Month
+3.76%
3 Months
-12.23%
Longer-term
6 Months -13.00%
1 Year +58.39%
2 Years +92.46%
3 Years +172.24%
5 Years N/A
10 Years N/A
AORT Stock Chart
AORT Stock Screens
AORT currently appears in the following ChartMill screener lists.
AORT Technical Analysis
ChartMill assigns a technical rating of 5 / 10 to AORT. When comparing the yearly performance of all stocks, AORT is one of the better performing stocks in the market, outperforming 78.46% of all stocks.
Chartmill TA Rating
Chartmill Setup Rating
AORT Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to AORT. AORT has an average financial health and profitability rating.
Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
AORT Earnings
On February 12, 2026 AORT reported an EPS of 0.05 and a revenue of 115.99M. The company missed EPS expectations (-39.98% surprise) and missed revenue expectations (-2.32% surprise).
Next Earnings DateApr 30, 2026
Last Earnings DateFeb 12, 2026
PeriodQ4 / 2025
EPS Reported$0.05
Revenue Reported115.992M
EPS Surprise -39.98%
Revenue Surprise -2.32%
AORT Forecast & Estimates
13 analysts have analysed AORT and the average price target is 52.46 USD. This implies a price increase of 38.92% is expected in the next year compared to the current price of 37.76.
For the next year, analysts expect an EPS growth of 143.83% and a revenue growth 11.86% for AORT
Analysts
Analysts83.08
Price Target52.46 (38.93%)
EPS Next Y143.83%
Revenue Next Year11.86%
AORT Groups
Sector & Classification
Sector
Health Care Sub-Industry
Health Care Equipment AORT Financial Highlights
Over the last trailing twelve months AORT reported a non-GAAP Earnings per Share(EPS) of 0.18. The EPS increased by 141.86% compared to the year before.
Income Statements
Revenue(TTM)441.33M
Net Income(TTM)9.76M
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 2.21% | ||
| ROA | 1.1% | ||
| ROE | 2.18% | ||
| Debt/Equity | 0.49 |
Chartmill High Growth Momentum
EPS Q2Q%112.82%
Sales Q2Q%19.2%
EPS 1Y (TTM)141.86%
Revenue 1Y (TTM)13.59%
AORT Ownership
Ownership
Inst Owners88.52%
Shares48.50M
Float44.50M
Ins Owners4.4%
Short Float %3.75%
Short Ratio3.47
AORT Competitors/Peers
The largest stocks on the US markets in the "Health Care Equipment" sub-industry
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ISRG | INTUITIVE SURGICAL INC | 41.34 | 170.062B | ||
| ABT | ABBOTT LABORATORIES | 14.5 | 160.7B | ||
| SYK | STRYKER CORP | 21.66 | 126.249B | ||
| BSX | BOSTON SCIENTIFIC CORP | 15.72 | 97.627B | ||
| EW | EDWARDS LIFESCIENCES CORP | 24.95 | 45.962B | ||
| IDXX | IDEXX LABORATORIES INC | 38.22 | 44.549B | ||
| BDX | BECTON DICKINSON AND CO | 11.15 | 44.092B | ||
| RMD | RESMED INC | 17.91 | 31.978B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 13.32 | 31.89B | ||
| DXCM | DEXCOM INC | 24.21 | 24.131B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 10.76 | 17.894B | ||
| PODD | INSULET CORP | 29.24 | 13.313B | ||
| PEN | PENUMBRA INC | 64.72 | 13.094B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find more growth stocks the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About AORT
Company Profile
Artivion, Inc. engages in the manufacture, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. The company is headquartered in Kennesaw, Georgia and currently employs 1,800 full-time employees. The firm is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. The company has four major product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Its Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. Its Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include its BioGlue Surgical Adhesive products.
Company Info
IPO: 1993-02-12
ARTIVION INC
1655 Roberts Boulevard N W
Kennesaw GEORGIA US
Employees: 1800
Phone: 17704193355
ARTIVION INC / AORT FAQ
Can you describe the business of ARTIVION INC?
Artivion, Inc. engages in the manufacture, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. The company is headquartered in Kennesaw, Georgia and currently employs 1,800 full-time employees. The firm is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. The company has four major product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Its Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. Its Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include its BioGlue Surgical Adhesive products.
What is the current price of AORT stock?
The current stock price of AORT is 37.76 USD. The price increased by 1.61% in the last trading session.
Does AORT stock pay dividends?
AORT does not pay a dividend.
What is the ChartMill technical and fundamental rating of AORT stock?
AORT has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
Which stock exchange lists AORT stock?
AORT stock is listed on the New York Stock Exchange exchange.
Can you provide the number of employees for ARTIVION INC?
ARTIVION INC (AORT) currently has 1800 employees.
Can you provide the market cap for ARTIVION INC?
ARTIVION INC (AORT) has a market capitalization of 1.83B USD. This makes AORT a Small Cap stock.